US Markets
PFE

Britain signs deals with Pfizer, BioNTech, Valneva for COVID-19 vaccines

Credit: REUTERS/DADO RUVIC

Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc and BioNTech alliance and French group Valneva, the business ministry said on Monday.

LONDON, July 20 (Reuters) - Britain has signed deals to secure 90 million doses of two possible COVID-19 vaccines from the Pfizer Inc PFE.N and BioNTech 22UAy.F alliance and French group Valneva VLS.PA, the business ministry said on Monday.

It said Britain had secured 30 million doses of the experimental BioNTech/Pfizer vaccine, and a deal in principle for 60 million doses of the Valneva vaccine, with a option of 40 million more doses if it was proven to be safe, effective and suitable.

(Reporting by Alistair Smout; Editing by Kim Coghill)

((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

PFE AZN

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More